Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis. (Q53470982)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 May 2010

Language	Label	Description	Also known as
English	Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.	scientific article published on 12 May 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

pulmonary fibrosis

1 reference

based on heuristic

inferred from title

idiopathic pulmonary fibrosis

1 reference

based on heuristic

inferred from title

pulmonary injury

1 reference

based on heuristic

inferred from title

author name string

Tae Hoon Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Yoo Hoon Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Kyung Hun Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Shin Hwa Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Ji Yeon Cha

5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Eun Kyoung Shin

6

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Seok Jung

7

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

An Soo Jang

8

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Sung Woo Park

9

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Soo Taek Uh

10

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Young Hoon Kim

11

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Jai Soung Park

12

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Hwa Gyoun Sin

13

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Wook Youm

14

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Eun Suk Koh

15

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Sun Young Cho

16

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Young Ki Paik

17

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Tai Youn Rhim

18

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Choon Sik Park

19

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

language of work or name

0 references

publication date

12 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

182

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

633-642

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Clinical features of interstitial lung diseases

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Mechanisms and mediators of pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Human bronchoalveolar lavage: biofluid analysis with special emphasis on sample preparation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Amiodarone pulmonary toxicity: cytopathology, ultrastructure, and immunocytochemistry

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Proteomic identification of macrophage migration-inhibitory factor upon exposure to TiO2 particles

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Is idiopathic pulmonary fibrosis an environmental disease?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

The protease inhibitor PI*S allele and COPD: a meta-analysis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Alpha1-antitrypsin phenotypes in patients with cryptogenic fibrosing alveolitis: a case-control study.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

The human plasma proteome: history, character, and diagnostic prospects

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Beneficial effects of ApoA-I on LPS-induced acute lung injury and endotoxemia in mice

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

On the structure and function of apolipoproteins: more than a family of lipid-binding proteins

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Bone morphogenetic protein-1 (BMP-1) cleaves human proapolipoprotein A1 and regulates its activation for lipid binding

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

ATP-binding cassette transporter A1 contains an NH2-terminal signal anchor sequence that translocates the protein's first hydrophilic domain to the exoplasmic space.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Localization of human ATP-binding cassette transporter 1 (ABC1) in normal and atherosclerotic tissues

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Expression and biological activity of ABCA1 in alveolar epithelial cells

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Roles of plasma lipid transfer proteins in reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Murine models of pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Inflammation/oxidation in chronic rejection: apolipoprotein a-i mimetic peptide reduces chronic rejection of transplanted hearts.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Neutrophils activation can be diminished by apolipoprotein A-I.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Apolipoprotein A-I attenuates renal ischemia/reperfusion injury in rats

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0659OC

21 January 2018

Identifiers

10.1164/RCCM.200905-0659OC

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20463180

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53470982&oldid=2256387973"